Territory Sales Representative
Hartford Territory
Launch Your Sales Career with Pivya® (pivmecillinam) at ImpactBio supporting Alembic Therapeutics!
Alembic Therapeutics, in partnership with ImpactBio, is launching Pivya®, an FDA-approved oral antibiotic for uncomplicated urinary tract infections (uUTIs). Used successfully for over 40 years in Denmark as a first-line therapy, Pivya® is now available to U.S. patients.
As a Territory Sales Representative, you’ll be part of this exciting U.S. launch, promoting Pivya® to healthcare providers in your territory. You’ll deliver effective product education, grow adoption, and establish trusted relationships—all while building your pharmaceutical sales career with a team that values your contributions.
This full-time role is with ImpactBio, a premier commercial partner in Life Sciences, with the potential to transition to Alembic Therapeutics based on strong performance. View Openings & Apply Here
Why This Role Matters
This role gives you the chance to make a meaningful impact early in your career while working on a high-profile product launch. Your ability to educate, engage, and influence healthcare providers will directly contribute to Alembic’s success in the U.S.
Key Responsibilities
What We’re Looking For
What We Offer
About Alembic Therapeutics
Alembic Therapeutics LLC, a U.S. subsidiary of Alembic Pharmaceuticals Inc., is committed to delivering high-quality, patient-focused branded pharmaceuticals. Our mission: bring innovative, reliable medicines to the U.S. market while upholding the highest standards of safety, efficacy, and quality.
About ImpactBio
At ImpactBio, we launch and scale teams differently—and it shows. We’re trusted by top life sciences companies and known for our dedication to clients, employees, healthcare providers, and patients alike. Join us and be part of something that makes a real impact.
Apply now:
View Openings & Apply Here
ImpactBio is an equal opportunity employer M/F/V/D. We appreciate your interest in our company, however; only qualified candidates will be considered.